Thanks so much @Cort and @Rachel Riggs for sharing this story. (I don't think I'm doing this @ thing right but I'm sure I'll figure it out some day!) It’s hard to summarise such a complex story – you make it look easy, Cort! Rachel, wow, you’ve been through the mill. Sorry you’ve had such a rocky road.
I was fascinated on many levels, including similarities in our stories, but especially the B-cell altering nature of copaxone as a possible explanation for its dramatic effect in you. Last year I read an account of one of the people in Fluge and Melle’s rituximab trial in Norway who had had a major response, i.e. basically recovered. I was struck by how similar her description of how her major response started was to an experience I had for a couple of weeks in 2013. I was on week 9 of a tetracycline antibiotic (same family as doxycycline) when I started getting these brighter windows. Not a big change but a very significant one for me – less brain fog, a little more stamina. This continued for a couple of weeks but I stopped the antibiotic after 12 weeks (as the non-ME issue it was prescribed for had resolved) and two medical appointments then finished me off. At the time I had attributed these brighter windows to starting thyroid meds, but in hindsight this wasn’t the case: the brighter windows started just a week into a very low dose of thyroid meds, and I’ve continued to deteriorate over time despite remaining on thyroid meds and increasing dose.
Guess what my pharmacist figured out? Tetracylines, like doxycycline, have B-cell depleting effects. http://m.intimm.oxfordjournals.org/content/13/7/921.full The delayed response (i.e. starting in week 9 of the antibiotic) would match up with the delayed response seen in ME/CFS responders to rituximab.
I saw that @Issie saw benefits with 3 years of doxycycline.
Gulp. Might long-term tetracycline antibiotics be able to modulate our immune systems? Might people with chronic Lyme disease who benefit from doxycycline be benefitting from B-cell depletion as well as or instead of antibiotic action?
Has anyone been on long-term subantimicrobial doses of doxycycline (maybe for periodontitis or rosacea) and noticed an improvement in their ME/CFS and/or POTS or orthostatic intolerance?
@Rachel Riggs, you might like these posts by a blogger who has both ME and POTS if you haven’t come across them already.
https://tipsforme.wordpress.com/2014/10/18/am-i-pots-or-is-it-just-me/
https://tipsforme.wordpress.com/2015/04/29/i-am-pots-but-whats-me/
Would be fascinated to hear more stories like this about accidental improvements on immunomodulating meds.
I was fascinated on many levels, including similarities in our stories, but especially the B-cell altering nature of copaxone as a possible explanation for its dramatic effect in you. Last year I read an account of one of the people in Fluge and Melle’s rituximab trial in Norway who had had a major response, i.e. basically recovered. I was struck by how similar her description of how her major response started was to an experience I had for a couple of weeks in 2013. I was on week 9 of a tetracycline antibiotic (same family as doxycycline) when I started getting these brighter windows. Not a big change but a very significant one for me – less brain fog, a little more stamina. This continued for a couple of weeks but I stopped the antibiotic after 12 weeks (as the non-ME issue it was prescribed for had resolved) and two medical appointments then finished me off. At the time I had attributed these brighter windows to starting thyroid meds, but in hindsight this wasn’t the case: the brighter windows started just a week into a very low dose of thyroid meds, and I’ve continued to deteriorate over time despite remaining on thyroid meds and increasing dose.
Guess what my pharmacist figured out? Tetracylines, like doxycycline, have B-cell depleting effects. http://m.intimm.oxfordjournals.org/content/13/7/921.full The delayed response (i.e. starting in week 9 of the antibiotic) would match up with the delayed response seen in ME/CFS responders to rituximab.
I saw that @Issie saw benefits with 3 years of doxycycline.
Gulp. Might long-term tetracycline antibiotics be able to modulate our immune systems? Might people with chronic Lyme disease who benefit from doxycycline be benefitting from B-cell depletion as well as or instead of antibiotic action?
Has anyone been on long-term subantimicrobial doses of doxycycline (maybe for periodontitis or rosacea) and noticed an improvement in their ME/CFS and/or POTS or orthostatic intolerance?
@Rachel Riggs, you might like these posts by a blogger who has both ME and POTS if you haven’t come across them already.
https://tipsforme.wordpress.com/2014/10/18/am-i-pots-or-is-it-just-me/
https://tipsforme.wordpress.com/2015/04/29/i-am-pots-but-whats-me/
Would be fascinated to hear more stories like this about accidental improvements on immunomodulating meds.